Bipolar Disorder News

A biopharmaceutical company announced it has dosed the first patient in a clinical trial of a long-acting oral treatment for schizophrenia, schizoaffective disorder and bipolar I disorder, according to a company press release.

More than half of people with bipolar disorder in Finland did not have at least one of their mood stabilizers or antipsychotic prescriptions dispensed, according to findings published in the Journal of Affective Disorders.

The FDA has approved a new drug application for aripiprazole, an extended-release injection for the treatment of schizophrenia and bipolar disorder, according to a press release from the manufacturers.

Analyses of blood metabolite profiles showed that people with a history of mental illness had a biological age older than their actual age, according to a presentation at the European Congress of Psychiatry.

Compared with other people with breast cancer, those with a preexisting severe mental illness were less likely to receive appropriate treatment and more likely to experience delays in receiving treatment, findings in Psycho-Oncology showed.

HHS announced it has awarded $1 million 1-year Certified Community Behavioral Health Clinic planning grants to 15 states through the Substance Abuse and Mental Health Services Administration.

Temporal self-appraisals and reflected appraisals were not similar in people with depression, but were similar in people with euthymic mood, according to data published in the Journal of Affective Disorders.

A mental health nonprofit has announced 11 companies will make up the inaugural cohort of a program that aims to help startups improve the lives of those with challenges relating to mental health conditions.

A generic pharmaceutical company announced the availability of a schizophrenia and bipolar depression treatment, according to a press release.

Children born to mothers, not fathers, with primary antibody immunodeficiencies had greater risks for certain psychiatric disorders and for suicidal behavior, according to data published in JAMA Psychiatry.